Zydus’ ZyCoV-D Receives the DCGI’s EUA for the Treatment of COVID-19

August 23, 2021 Auto Bot EUA, regulatory, ZyCoV-D, Zydus 0

Shots:

  • The DCGI has granted a EUA for ZyCoV-D which is the world’s first plasmid DNA vaccine for COVID-19. The company is planning to seek approval for the two-dose regimen of the vaccine
  • ZyCoV-D will become India’s first vaccine for adolescents aged 12-18 yrs. The vaccine is safe and well-tolerated
  • ZyCoV-D is a three-dose, needle-free, intradermal vaccine that leads to a reduction in any side effects & administered using PharmaJet for painless delivery. The company plans to manufacture 10-12 crore doses annually

Click here to­ read full press release/ article | Ref: PRNewswire | Image: Zydus

The post Zydus’ ZyCoV-D Receives the DCGI’s EUA for the Treatment of COVID-19 first appeared on PharmaShots.